Literature DB >> 11687601

Inheritance of osteosarcoma and Paget's disease of bone: a familial loss of heterozygosity study.

J D McNairn1, T A Damron, S K Landas, J L Ambrose, A E Shrimpton.   

Abstract

Pagetoid osteosarcoma is a complication of Paget's disease of bone. Sarcomatous transformation is most often seen in severe, long-standing Paget's disease. Familial clustering of Paget's disease has been described with apparent autosomal dominant inheritance with high penetrance by the sixth decade. Although definitive proof of the specific gene involved remains elusive, some researchers have shown loss of heterozygosity in a region of chromosome 18q in a relatively high percentage of studied patients affected with either Paget's disease alone, in Pagetoid osteosarcoma, and in uncomplicated osteosarcoma. Our patient was diagnosed with Pagetoid osteosarcoma and had a first-degree relative with history of the same. We hypothesized that our patient's tumor samples might contain a similar genetic abnormality. Our analysis of several polymorphic markers from the chromosome 18q21-22 region showed loss of maternally inherited alleles throughout the region. This finding is similar to those described previously and provides further evidence of a susceptibility region relating to this disease. This report describes a father and son, their young ages at diagnosis of Pagetoid sarcoma, the identical sites of disease involvement, and a loss of heterozygosity study illustrating the inheritance of the presumed defective gene.

Entities:  

Mesh:

Year:  2001        PMID: 11687601      PMCID: PMC1906967          DOI: 10.1016/S1525-1578(10)60669-1

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  35 in total

Review 1.  Paget's disease from a genetic perspective.

Authors:  W Van Hul
Journal:  Bone       Date:  1999-05       Impact factor: 4.398

2.  Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcoma.

Authors:  A B Sparks; S N Peterson; C Bell; B J Loftus; L Hocking; D P Cahill; F J Frassica; E A Streeten; M A Levine; C M Fraser; M D Adams; S Broder; J C Venter; K W Kinzler; B Vogelstein; S H Ralston
Journal:  Calcif Tissue Int       Date:  2001-03       Impact factor: 4.333

3.  Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis.

Authors:  A E Hughes; S H Ralston; J Marken; C Bell; H MacPherson; R G Wallace; W van Hul; M P Whyte; K Nakatsuka; L Hovy; D M Anderson
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

4.  Osteolytic Paget's disease. Recognition and risks of biopsy.

Authors:  J A Eisman; T J Martin
Journal:  J Bone Joint Surg Am       Date:  1986-01       Impact factor: 5.284

5.  Extensive personal experience: Paget's disease of bone.

Authors:  E S Siris
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

6.  Bone sarcomas in Paget disease.

Authors:  H G Greditzer; R A McLeod; K K Unni; J W Beabout
Journal:  Radiology       Date:  1983-02       Impact factor: 11.105

7.  Extramedullary granulopoiesis mimicking recurrent lymphoma after prolonged administration of human recombinant granulocyte colony-stimulating factor.

Authors:  H D Friedman; S O Sanderson; C K Stein; A Shrimpton; N J Gonchoroff; K W Zamkoff; T P Loughran
Journal:  Ann Hematol       Date:  1998 Jul-Aug       Impact factor: 3.673

8.  Familial osteogenic sarcoma occurring in pagetoid bone.

Authors:  V H Nassar; M B Gravanis
Journal:  Am J Clin Pathol       Date:  1981-08       Impact factor: 2.493

9.  A significant proportion of patients with osteosarcoma may belong to Li-Fraumeni cancer families.

Authors:  D E Porter; S T Holden; C M Steel; B B Cohen; M R Wallace; R Reid
Journal:  J Bone Joint Surg Br       Date:  1992-11

10.  Fourteen cases of sarcomatous degeneration in Paget's disease.

Authors:  F Jattiot; P Goupille; I Azais; B Roulot; M Alcalay; J Jeannou; D Bontoux; J P Valat
Journal:  J Rheumatol       Date:  1999-01       Impact factor: 4.666

View more
  8 in total

1.  Degeneration of Paget's disease into sarcoma: clinical and therapeutic influencing factors.

Authors:  Alessandro Zati; Teresa Wanda Bilotta
Journal:  Chir Organi Mov       Date:  2008-04-12

2.  Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate.

Authors:  S Jabeen; L Holmboe; G I G Alnæs; A M Andersen; K S Hall; V N Kristensen
Journal:  Pharmacogenomics J       Date:  2015-03-17       Impact factor: 3.550

Review 3.  Osteosarcoma development and stem cell differentiation.

Authors:  Ni Tang; Wen-Xin Song; Jinyong Luo; Rex C Haydon; Tong-Chuan He
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

4.  The Current and Future Therapies for Human Osteosarcoma.

Authors:  Joseph D Lamplot; Sahitya Denduluri; Jiaqiang Qin; Ruidong Li; Xing Liu; Hongyu Zhang; Xiang Chen; Ning Wang; Abdullah Pratt; Wei Shui; Xiaoji Luo; Guoxin Nan; Zhong-Liang Deng; Jinyong Luo; Rex C Haydon; Tong-Chuan He; Hue H Luu
Journal:  Curr Cancer Ther Rev       Date:  2013-02

5.  Defective osteogenic differentiation in the development of osteosarcoma.

Authors:  Eric R Wagner; Gaurav Luther; Gaohui Zhu; Qing Luo; Qiong Shi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Yanhong Gao; Ke Yang; Linyuan Wang; Chad Teven; Xiaoji Luo; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Yang Bi; Bai-Cheng He; Ni Tang; Jinyong Luo; Liang Chen; Guowei Zuo; Richard Rames; Rex C Haydon; Hue H Luu; Tong-Chuan He
Journal:  Sarcoma       Date:  2011-02-22

6.  Segregation of a M404V mutation of the p62/sequestosome 1 (p62/SQSTM1) gene with polyostotic Paget's disease of bone in an Italian family.

Authors:  Alberto Falchetti; Marco Di Stefano; Francesca Marini; Francesca Del Monte; Alessia Gozzini; Laura Masi; Annalisa Tanini; Antonietta Amedei; Annamaria Carossino; Giancarlo Isaia; Maria Luisa Brandi
Journal:  Arthritis Res Ther       Date:  2005-09-15       Impact factor: 5.156

Review 7.  Risk Factors for Development of Canine and Human Osteosarcoma: A Comparative Review.

Authors:  Kelly M Makielski; Lauren J Mills; Aaron L Sarver; Michael S Henson; Logan G Spector; Shruthi Naik; Jaime F Modiano
Journal:  Vet Sci       Date:  2019-05-25

Review 8.  Osteosarcoma mechanobiology and therapeutic targets.

Authors:  Zunaira Shoaib; Timothy M Fan; Joseph M K Irudayaraj
Journal:  Br J Pharmacol       Date:  2021-12-21       Impact factor: 9.473

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.